PortfoliosLab logoPortfoliosLab logo
TALK vs. LTRN
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

TALK vs. LTRN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Talkspace, Inc. (TALK) and Lantern Pharma Inc. (LTRN). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

TALK vs. LTRN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
TALK
Talkspace, Inc.
42.15%17.48%21.65%316.19%-69.02%-81.78%7.03%
LTRN
Lantern Pharma Inc.
-53.14%-5.02%-25.47%-29.14%-24.31%-58.55%57.53%

Fundamentals

EPS

TALK:

-$0.03

LTRN:

-$1.75

Total Revenue (TTM)

TALK:

$228.87M

LTRN:

$0.00

Gross Profit (TTM)

TALK:

$98.35M

LTRN:

-$55.33K

EBITDA (TTM)

TALK:

$11.89M

LTRN:

-$19.41M

Returns By Period

In the year-to-date period, TALK achieves a 42.15% return, which is significantly higher than LTRN's -53.14% return.


TALK

1D
-0.29%
1M
4.67%
YTD
42.15%
6M
91.11%
1Y
93.98%
3Y*
95.07%
5Y*
-12.41%
10Y*

LTRN

1D
3.65%
1M
-47.01%
YTD
-53.14%
6M
-65.53%
1Y
-57.10%
3Y*
-33.51%
5Y*
-41.02%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Talkspace, Inc.

Lantern Pharma Inc.

Return for Risk

TALK vs. LTRN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TALK
TALK Risk / Return Rank: 8585
Overall Rank
TALK Sharpe Ratio Rank: 8787
Sharpe Ratio Rank
TALK Sortino Ratio Rank: 8787
Sortino Ratio Rank
TALK Omega Ratio Rank: 8282
Omega Ratio Rank
TALK Calmar Ratio Rank: 8585
Calmar Ratio Rank
TALK Martin Ratio Rank: 8282
Martin Ratio Rank

LTRN
LTRN Risk / Return Rank: 1313
Overall Rank
LTRN Sharpe Ratio Rank: 1414
Sharpe Ratio Rank
LTRN Sortino Ratio Rank: 1818
Sortino Ratio Rank
LTRN Omega Ratio Rank: 1818
Omega Ratio Rank
LTRN Calmar Ratio Rank: 1414
Calmar Ratio Rank
LTRN Martin Ratio Rank: 22
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TALK vs. LTRN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Talkspace, Inc. (TALK) and Lantern Pharma Inc. (LTRN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


TALKLTRNDifference

Sharpe ratio

Return per unit of total volatility

1.76

-0.62

+2.38

Sortino ratio

Return per unit of downside risk

2.60

-0.53

+3.14

Omega ratio

Gain probability vs. loss probability

1.31

0.93

+0.38

Calmar ratio

Return relative to maximum drawdown

3.04

-0.76

+3.80

Martin ratio

Return relative to average drawdown

7.00

-1.89

+8.89

TALK vs. LTRN - Sharpe Ratio Comparison

The current TALK Sharpe Ratio is 1.76, which is higher than the LTRN Sharpe Ratio of -0.62. The chart below compares the historical Sharpe Ratios of TALK and LTRN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


TALKLTRNDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.76

-0.62

+2.38

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.18

-0.50

+0.32

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.17

-0.40

+0.23

Correlation

The correlation between TALK and LTRN is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

TALK vs. LTRN - Dividend Comparison

Neither TALK nor LTRN has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

TALK vs. LTRN - Drawdown Comparison

The maximum TALK drawdown since its inception was -95.17%, roughly equal to the maximum LTRN drawdown of -94.89%. Use the drawdown chart below to compare losses from any high point for TALK and LTRN.


Loading graphics...

Drawdown Indicators


TALKLTRNDifference

Max Drawdown

Largest peak-to-trough decline

-95.17%

-94.89%

-0.28%

Max Drawdown (1Y)

Largest decline over 1 year

-33.43%

-78.95%

+45.52%

Max Drawdown (5Y)

Largest decline over 5 years

-94.17%

-94.37%

+0.20%

Current Drawdown

Current decline from peak

-57.36%

-93.52%

+36.16%

Average Drawdown

Average peak-to-trough decline

-68.92%

-65.55%

-3.37%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.51%

31.71%

-17.20%

Volatility

TALK vs. LTRN - Volatility Comparison

The current volatility for Talkspace, Inc. (TALK) is 8.40%, while Lantern Pharma Inc. (LTRN) has a volatility of 65.87%. This indicates that TALK experiences smaller price fluctuations and is considered to be less risky than LTRN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


TALKLTRNDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.40%

65.87%

-57.47%

Volatility (6M)

Calculated over the trailing 6-month period

38.20%

80.20%

-42.00%

Volatility (1Y)

Calculated over the trailing 1-year period

53.69%

92.57%

-38.88%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

69.27%

83.11%

-13.84%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

65.91%

83.75%

-17.84%

Financials

TALK vs. LTRN - Financials Comparison

This section allows you to compare key financial metrics between Talkspace, Inc. and Lantern Pharma Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00M20.00M30.00M40.00M50.00M60.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
63.00M
0
(TALK) Total Revenue
(LTRN) Total Revenue
Values in USD except per share items